Pay in 4 interest-free payments of $6.80 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Retatrutide GLP-1/GIP/glucagon triple agonist studied in adiposity and metabolic-rate research
Important Safety Reminders Medical Supervision Required: AOD-9604 should only be used under qualified medical supervision Baseline and monitoring laboratory testing is recommended Individual contraindications and health status must be evaluated AOD-9604 is not FDA-approved for any indication Contraindications and Precautions: Pregnancy and breastfeeding (no safety data available) Active malignancy (discuss with oncologist) Pediatric use (not studied in children) Significant organ dysfunction (limited safety data) Report Concerns: Any unexpected symptoms or adverse effects should be reported to your healthcare provider promptly
Your provider monitors comfort and reviews hydration, activity, and follow-up guidance before you leave
Compound Information Blend composition: 70 mg total per vial (50 mg GHK-Cu, 10 mg BPC-157, 10 mg TB-500)
If you have one or multiple common symptoms, your doctor may suspect that youre suffering from endometriosis, Greves says
